An Open and Socially Responsible Healthcare Group https://nitter.cf/t.co/NjSBQdsIzb / [email protected]
Bellevue, WA
Joined March 2025
- Tweets118
- Following20
- Followers87
- Likes18
OSR Health retweeted
$OSRH $15 million in funding at a very high premium (in 4 Tranches)
sec.gov/ix?doc=/Archives/edg…
OSR Health retweeted
$OSRH Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its ... accessnewswire.com/newsroom/…
OSR Health retweeted
#Vaximm AG, an #OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform biotechnewswire.ai/202608032… #biotech #oncology #immunotherapy @immunotherapy @sitcancer
OSR Health retweeted
$OSRH Live Emerging Growth Conference 92 - May 6 & 7
@OSRHoldings
Register:
goto.webcasts.com/starthere.…
Questions for the Company? [email protected]
To Present on the Conference:
305-330-1985
[email protected]
OSR Health retweeted
$OSRH Investor Call Disclosure:
OSR Holdings, Inc. reported details of a March 13, 2026 investor call where information about potential licensing with SillaJen and discussions on acquiring a 16% stake were inadvertently shared. The negotiations for licensing and acquisition are still in early stages, without any agreements yet.
stockinsights.ai/us/OSRH/8-K…
OSR Health retweeted
투자자 여러분을 대상으로 아래와 같이 온라인 기업설명회를 개최하오니 많은 관심과 참여 부탁드립니다.
일시: 2025년 4월 25일 (금) 오후 9시 (한국시간)
주요 내용:
• 회사 소개 및 비전
• 주요 자회사 현황 및 전략
• 향후 성장 계획 및 재무 전망
• Q&A 세션
us06web.zoom.us/j/8156154818…
OSR Health retweeted
$OSRH Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma